StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) operating KPIs

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.68+5.07 (+3.06%)

Close on Oct 30, 2026Market cap $211.64BP/E –Yield 1.85%

Gilead Sciences rate of recordable work-related injuries per 200,000 hours (TRIR)

Gilead Annual Impact Reports (2023–2025)

Latest, FY2025
0.36
Period ended Dec 31, 2025
Change on a year earlier
-39.0%
0.59 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRate of recordable work-related injuries per 200,000 hours (TRIR)Year on yearSource
FY2025Dec 31, 20250.36-39.0%Gilead Sustainability / IR (2025-impact-report.pdf) ↗
FY2024Dec 31, 20240.59-32.2%Gilead Sustainability / IR (2025-impact-report.pdf) ↗
FY2023Dec 31, 20230.87-28.7%Gilead Sustainability / IR (2025-impact-report.pdf) ↗
FY2022Dec 31, 20221.22+165.2%Gilead Sustainability / IR (2024-responsible-business-and-impact-report.pdf) ↗
FY2021Dec 31, 20210.46–Gilead Sustainability / IR (2023-environmental-social-governance-impact-report.pdf) ↗

Cite this data

StockData. (2026). Gilead Sciences Rate of recordable work-related injuries per 200,000 hours (TRIR), annual FY2021–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/esg_safety_trir

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.